Dell's Strong Earnings Propel Tech Stocks Higher

The major averages closed higher on the last trading day of the month as Dell's blowout results helped add fuel to the ongoing rally in tech.Oil prices pulled back amid further diplomatic signaling around Iran, although it was reported that Iran's armed forces fired missiles late Thursday and President Trump said in a social media post that he was meeting to decide if he would approve a deal to extend the ceasefire.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Dell Technologiesprovided areport for Q1Costcoreported, though comparable-store sales rose 9.8% year-over-yearGapreportedand raised its FY26 net interest income outlookAutodeskprovided areport for Q1 and agreed to acquire MaintainX in a deal valued at $3.6BSeveral space stocks, including AST SpaceMobile, EchoStar, and Rocket Lab, were slipping after Blue Origin's New Glenn rocketin Cape Canaveral2. WALL STREET CALLS:SusquehannaDellto Positive, hiked its price target to $700HSBCSnowflaketo Buy on AI visibilityDeutscheAST SpaceMobileafter the Blue Origin New Glenn rocket explosionBest Buyto Neutral at UBSSentinelOneto Buy at BofA and downgraded to Market Perform at Raymond James after Q1 report3. AROUND THE WEB:Mercedes-Benzcould be shut out of U.S. car market under a new bill, CNBC reportsNvidia'splans to launch Rubin CPX, an inference-focused graphics processing unit for its Vera Rubin platform, has become "increasingly uncertain" as supply chain activity around the product appears to have stalled, The Elec saysMetais creating an Enterprise Solutions unit that embeds engineers and product managers directly with large corporate customers to accelerate adoption and deployment of its AI tools, The Information reportsJD.comfounder Liu Qiangdong has pledged to prioritize protecting the company's roughly 900,000 employees from AI-driven automation, Bloomberg reportsMassachusetts Attorney General Andrea Joy Campbell is suing UnitedHealth'sUnitedHealthcare, alleging the subsidiary purposefully made low-income older adults appear sicker to boost its bottom line, Stat News says4. MOVERS:Replimuneincreases afterfor RP1 in combination with nivolumab following communications with the FDANetAppand PagerDutywere higher afterOktagained afterand raising its guidance for FY27Ambarellafell afterand providing guidance for Q2iHeartMediawas lower after DealBooktalks over a potential sale to Sirius XMare on pause5. EARNINGS/GUIDANCE:Genescoand raised its guidance for FY27Elmet, with EPS and revenue beating consensusTempus AIreiteratedHealthEquityand raised its guidance for FY27UiPath, provided guidance for Q2, and raised its outlook for FY27INDEXES:The Dow rose 363.49, or 0.72%, to 51,032.46, the Nasdaq gained 55.15, or 0.20%, to 26,972.62, and the S&P 500 advanced 16.43, or 0.22%, to 7,580.06.